Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma

JAMA Otolaryngology - Head and Neck Surgery

Volumn 140, Issue 2, 2014, Pages 134-142

  Chinn, Steven B ^a   Spector, Matthew E ^a   Bellile, Emily L ^b   Rozek, Laura S ^b   Lin, Tasha ^a   Teknos, Theodoros N ^a,c   Prince, Mark E ^a,b   Bradford, Carol R ^a,b   Urba, Susan G ^a,b   Carey, Thomas E ^a,b   Eisbruch, Avraham ^b   Wolf, Gregory T ^a   Worden, Francis P ^a,b   Chepeha, Douglas B ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MONTE CARLO METHOD; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORAL SURGICAL PROCEDURES; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84894428188     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.5892     Document Type: Article

References (25)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212-236.
2. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23(4):705-713.
3. Ang KK. Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes. Oncologist. 2008;13(8):899-910.
4. Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4-14.
5. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T; EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996;88(13):890-899. (Pubitemid 26230640)
6. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685-1690.
7. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol. 2006;24(4):593-598. (Pubitemid 46630421)
8. Urba SG, Moon J, Giri PG, et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group trial. J Clin Oncol. 2005;23(1):88-95. (Pubitemid 41702626)
9. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008;26(19):3138-3146.
10. Bergstralh EJ. Computerized Matching of Controls: Section of Biostatistics Technical Report 56. Rochester, MN: Mayo Foundation; 1985.
11. Rosenbaum PR. Optimal matching in observational studies. JASA. 1989;84(498):1024-1032.
12. Cooper JS, Pajak TF, Forastiere A, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck. 1998;20(7):588-594. (Pubitemid 28405799)
13. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27(10):843-850. (Pubitemid 41395696)
14. Sher DJ, Thotakura V, Balboni TA, et al. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;81(4):e215-e222. doi:10.1016/j.ijrobp.2011.02.023.
15. Umeda M, Komatsubara H, Ojima Y, et al. Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU). Kobe J Med Sci. 2004;50(5-6):189-196. (Pubitemid 41283765)
16. Cohen EE, Baru J, Huo D, et al. Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head Neck. 2009;31(8):1013-1021.
17. Stenson KM, Kunnavakkam R, Cohen EE, et al. Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope. 2010;120(1):93-99.
18. Pederson AW, Salama JK, Witt ME, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol. 2011;34(4):356-361.
19. Gilbert EH, Goffinet DR, Bagshaw MA. Carcinoma of the oral tongue and floor of mouth: fifteen years' experience with linear acceleration therapy. Cancer. 1975;35(6):1517-1524.
20. Marcial VA, Pajak TF. Radiation therapy alone or in combination with surgery in head and neck cancer. Cancer. 1985;55(9)(suppl):2259-2265. (Pubitemid 15119193)
21. Ildstad ST, Bigelow ME, Remensnyder JP. Intra-oral cancer at the Massachusetts General Hospital: squamous cell carcinoma of the floor of the mouth. Ann Surg. 1983;197(1):34-41. (Pubitemid 13211721)
22. Gluck I, Feng FY, Lyden T, et al. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;77(3):727-733.
23. Chepeha DB, Teknos TN, Shargorodsky J, et al. Rectangle tongue template for reconstruction of the hemiglossectomy defect. Arch Otolaryngol Head Neck Surg. 2008;134(9):993-998.
24. de Bree R, Rinaldo A, Genden EM, et al. Modern reconstruction techniques for oral and pharyngeal defects after tumor resection. Eur Arch Otorhinolaryngol. 2008;265(1):1-9. (Pubitemid 350160365)
25. Vos JD, Burkey BB. Functional outcomes after free flap reconstruction of the upper aerodigestive tract. Curr Opin Otolaryngol Head Neck Surg. 2004;12(4):305-310. (Pubitemid 38970727)